What will Norway’s infliximab switching study tell us about the safety of switching patients from one biologic medicine to a biosimilar?
From the Blog
Patients at the Heart of New Cholesterol Guidelines
September 16, 2019
Heart Attack, Stroke Data Highlight Value of Prevention
August 13, 2019